Hot Debate: Should GLP-1 Receptor Agonists Be Prioritized as Standard Care in CKD Management?
Back
29 Mar 2026
3:45 p.m.
4:45 p.m.
Main Hall
Time
Session
3:45 p.m.
4:05 p.m.
GLP-1 Receptor Agonists Are a Game-changing Therapy and Should Be Integrated Into CKD Standard of Care, Globally
4:05 p.m.
4:25 p.m.
Widespread Use of GLP-1 RAs is Premature, Unaffordable, and Risks Widening Global Kidney Care Disparities